Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tick-borne encephalitis virus vaccine
- Development stage
- Approved
- Lead developer
- Pfizer
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Tick-borne encephalitis virus vaccine is an inactivated viral vaccine used for active immunization to prevent infection by the tick-borne encephalitis (TBE) virus. The TBE virus is endemic in parts of Europe and Asia and can cause severe neurologic disease. The vaccine works by stimulating the immune system to produce antibodies against the TBE virus, providing protection before exposure. It is administered intramuscularly as a three-dose primary series with a possible booster dose if ongoing risk exists. The most widely available formulation in the United States is marketed as Ticovac and manufactured by Pfizer; other brands are available internationally. The World Health Organization recommends vaccination for people living in or traveling to endemic areas who are at increased risk of exposure[1][3][5][7].
- Brand names
- TicovacEncepur NFSME-Immun CC
- Other names
- TBE vaccinetick-borne encephalitis vaccine
Beyond the preview
Go deeper on tick-borne encephalitis virus vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tick-borne encephalitis virus vaccine.